Omega-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid enhance dexamethasone sensitivity in multiple myeloma cells by the p53/miR-34a/Bcl-2 axis
- 54 Downloads
Dexamethasone is widely used in multiple myeloma (MM) for its cytotoxic effects on lymphoid cells. However, many MM patients are resistant to dexamethasone, although some can benefit from dexamethasone treatment. In this study, we noted that ω-3 polyunsaturated fatty acids (PUFAs) enhanced the dexamethasone sensitivity of MM cells by inducing cell apoptosis. q-PCR analysis revealed that miR-34a could be significantly induced by PUFAs in U266 and primary MM cells. Transfection with miR-34a antagonist or miR-34a agomir could restore or suppress the dexamethasone sensitivity in U266 cells. Both luciferase reporter assay and Western blot showed that Bcl-2 is the direct target of miR-34a in MM cells. In addition, we observed that PUFAs induced p53 protein expression in MM cells under dexamethasone administration. Furthermore, suppressing p53 by its inhibitor, Pifithrin-α, regulated the miR-34a expression and modulated the sensitivity to dexamethasone in U266 cells. In summary, these results suggest that PUFAs enhance dexamethasone sensitivity to MM cells through the p53/miR-34a axis with a likely contribution of Bcl-2 suppression.
Keywordspolyunsaturated fatty acids eicosapentaenoic acid docosahexaenoic acid dexamethasone apoptosis miR-34a p53 Bcl-2
- MTT (test)
ω-3 polyunsaturated fatty acids
Unable to display preview. Download preview PDF.
- 10.Merendino, N., Costantini, L., Manzi, L., Molinari, R., D’Eliseo, D., and Velotti, F. (2013) Dietary omega-3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer, Biomed Res. Int., 310186.Google Scholar
- 13.Kervoelen, C., Menoret, E., Gomez-Bougie, P., Bataille, R., Godon, C., Marionneau-Lambot, S., Moreau, P., Pellat-Deceunynck, C., and Amiot, M. (2015) Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma, Oncotarget, 6, 26922–26934.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Colas, S., Maheo, K., Denis, F., Goupille, C., Hoinard, C., Champeroux, P., Tranquart, F., and Bougnoux, P. (2006) Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vas-cularization, Clin. Cancer Res., 12, 5879–5886.CrossRefPubMedGoogle Scholar
- 19.Daak, A. A., Elderdery, A. Y., Elbashir, L. M., Mariniello, K., Mills, J., Scarlett, G., Elbashir, M. I., and Ghebremeskel, K. (2015) Omega-3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-kappaB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease, Blood Cells Mol. Dis., 55, 48–55.CrossRefPubMedGoogle Scholar
- 20.Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R., Tapping, R., Feng, L., Lee, W. H., Fitzgerald, K. A., and Hwang, D. H. (2004) Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1, J. Biol. Chem., 279, 16971–16979.CrossRefPubMedGoogle Scholar
- 25.Cheng, C. J., Bahal, R., Babar, I. A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D. T., Glazer, P. M., Engelman, D. M., Saltzman, W. M., and Slack, F. J. (2015) MicroRNA silencing for cancer therapy targeted to the tumour microenvironment, Nature, 518, 107–110.CrossRefPubMedGoogle Scholar